Lineage Cell Therapeutics, Inc. (LCTX) has 25 open-market insider trades by 16 insiders since 2019. The most active filer is Brian M. Culley, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Broadwood Partners, L.P. | Dir10% Owner | — | 1 | $14.0M | 2024-02-06 |
| Broadwood Capital Inc. via Neal C. Bradsher | Dir10% Owner | — | 2 | $12.0M | 2025-01-27 |
| Gary S. Hogge | VP | — | 1 | $2.6M | 2023-02-11 |
| Neal C. Bradsher | Dir10% Owner | — | 1 | $1.7M | 2022-03-25 |
| Brian M. Culley | CEOPres | — | 7 | $1.4M | 2026-03-12 |
| Don M. Bailey | Dir | — | 1 | $200K | 2024-02-08 |
| Dipti Amin | Dir | — | 1 | $114K | 2022-03-28 |
| Deborah J. Andrews | Dir | — | 1 | $112K | 2021-06-29 |
| Michael H. Mulroy | Dir | — | 2 | $33K | 2024-11-22 |
| Jill Ann Howe | CFO | — | 2 | $18K | 2024-11-26 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Brian M. Culley | President | Buy | $24K | 2026-03-12 |
| Broadwood Capital Inc. | Director & 10% Owner | Buy | $12.0M | 2025-01-27 |
| Jill Ann Howe | CFO | Buy | $9K | 2024-11-26 |
| George A. Samuel III | General Counsel | Buy | $9K | 2024-11-26 |
| Michael H. Mulroy | Director | Buy | $23K | 2024-11-22 |
| Brian M. Culley | President | Buy | $24K |
Companies that share insiders with LCTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-11-21 |
| Jill Ann Howe | CFO | Buy | $9K | 2024-08-16 |
| Brian M. Culley | President | Buy | $11K | 2024-05-24 |
| Don M. Bailey | Director | Buy | $200K | 2024-02-08 |
| Broadwood Partners, L.P. | Director & 10% Owner | Buy | $14.0M | 2024-02-06 |
| Anula Jayasuriya | Director | Buy | $11K | 2023-12-29 |
| Brian M. Culley | President | Buy | $10K | 2022-03-31 |
| Dipti Amin | Director | Buy | $114K | 2022-03-28 |
| Brian M. Culley | President | Buy | $7K | 2022-03-25 |
| Michael H. Mulroy | Director | Buy | $10K | 2022-03-24 |